FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2076134474> ?p ?o ?g. }

• W2076134474 endingPage "792" @default.
• W2076134474 startingPage "785" @default.
• W2076134474 abstract "To evaluate accelerated hyperfractionated radiotherapy for the treatment of malignant gliomas.Between April 1985 and June 1994, 70 adult patients with pathologically confirmed malignant glioma (75% glioblastoma multiforme, 25% anaplastic astrocytoma) suitable for high-dose therapy were selected for treatment with accelerated hyperfractionated radiotherapy, 1.5 Gy twice daily to a total target dose of 60 Gy. Two patients were excluded from analysis (one patient had a fatal pulmonary embolism after 18 Gy; one patient discontinued therapy after 28.5 Gy against medical advice and without sequelae or progression). The 68 patients in the study group had a median age of 52 years and a median Karnofsky performance status of 90. Stereotactic implant (125I) or stereotactic radiosurgery boosts were delivered to 16 patients (24%) in the study group. Minimum follow-up was 6 months.Median survival was 13.8 months and median progression-free survival was 7.4 months. The absolute Kaplan-Meier survival rate was 16% at 2 years and 4% at 5 years. Multivariate analysis for the prognostic impact of age, gender, histology, Karnofsky performance status, symptomatology, surgical resection vs. biopsy, and boost vs. nonboost therapy revealed that Karnofsky performance status > or = 90, boost therapy, and surgical excision predicted significantly improved outcome. No severe toxicity occurred in patients treated with accelerated hyperfractionated radiotherapy alone, although 5% required steroids temporarily for edema. Progression occurred during treatment in one patient (1.5%).This regimen of accelerated hyperfractionated radiotherapy is well tolerated and leads to results comparable with those of standard therapy. The rate of disease progression during treatment is significantly better (p = 0.001) than is reported for patients treated with standard fractionation, with or without chemotherapy. This regimen is a reasonable starting point for future trials and may have some advantages over standard fractionation." @default.
• W2076134474 created "2016-06-24" @default.
• W2076134474 creator A5000041413 @default.
• W2076134474 creator A5008642709 @default.
• W2076134474 creator A5040980527 @default.
• W2076134474 creator A5048904323 @default.
• W2076134474 creator A5060755285 @default.
• W2076134474 date "1996-03-01" @default.
• W2076134474 modified "2023-09-25" @default.
• W2076134474 title "Accelerated hyperfractionated radiotherapy for malignant gliomas" @default.
• W2076134474 cites W1508981216 @default.
• W2076134474 cites W1966475493 @default.
• W2076134474 cites W1971190576 @default.
• W2076134474 cites W1974997339 @default.
• W2076134474 cites W1988443774 @default.
• W2076134474 cites W1991881143 @default.
• W2076134474 cites W2000501172 @default.
• W2076134474 cites W2001660159 @default.
• W2076134474 cites W2002635627 @default.
• W2076134474 cites W2004685270 @default.
• W2076134474 cites W2007365761 @default.
• W2076134474 cites W2023002553 @default.
• W2076134474 cites W2025530313 @default.
• W2076134474 cites W2027501539 @default.
• W2076134474 cites W2029445057 @default.
• W2076134474 cites W2036560693 @default.
• W2076134474 cites W2040243935 @default.
• W2076134474 cites W2041405351 @default.
• W2076134474 cites W2059609023 @default.
• W2076134474 cites W2060874863 @default.
• W2076134474 cites W2077668530 @default.
• W2076134474 cites W2085340609 @default.
• W2076134474 cites W2088925558 @default.
• W2076134474 cites W2113012900 @default.
• W2076134474 cites W2117322456 @default.
• W2076134474 cites W2158850894 @default.
• W2076134474 cites W2160552840 @default.
• W2076134474 cites W2161340139 @default.
• W2076134474 cites W2167712950 @default.
• W2076134474 cites W2168934883 @default.
• W2076134474 cites W2275889916 @default.
• W2076134474 cites W4293241248 @default.
• W2076134474 doi "https://doi.org/10.1016/0360-3016(95)02157-4" @default.
• W2076134474 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8598354" @default.
• W2076134474 hasPublicationYear "1996" @default.
• W2076134474 type Work @default.
• W2076134474 sameAs 2076134474 @default.
• W2076134474 citedByCount "33" @default.
• W2076134474 countsByYear W20761344742013 @default.
• W2076134474 countsByYear W20761344742014 @default.
• W2076134474 countsByYear W20761344742017 @default.
• W2076134474 crossrefType "journal-article" @default.
• W2076134474 hasAuthorship W2076134474A5000041413 @default.
• W2076134474 hasAuthorship W2076134474A5008642709 @default.
• W2076134474 hasAuthorship W2076134474A5040980527 @default.
• W2076134474 hasAuthorship W2076134474A5048904323 @default.
• W2076134474 hasAuthorship W2076134474A5060755285 @default.
• W2076134474 hasConcept C141071460 @default.
• W2076134474 hasConcept C155806632 @default.
• W2076134474 hasConcept C2776694085 @default.
• W2076134474 hasConcept C2776755627 @default.
• W2076134474 hasConcept C2778227246 @default.
• W2076134474 hasConcept C2778880634 @default.
• W2076134474 hasConcept C2779083369 @default.
• W2076134474 hasConcept C2780147359 @default.
• W2076134474 hasConcept C2780387249 @default.
• W2076134474 hasConcept C2780739268 @default.
• W2076134474 hasConcept C2781413609 @default.
• W2076134474 hasConcept C2908786992 @default.
• W2076134474 hasConcept C502942594 @default.
• W2076134474 hasConcept C509974204 @default.
• W2076134474 hasConcept C71924100 @default.
• W2076134474 hasConceptScore W2076134474C141071460 @default.
• W2076134474 hasConceptScore W2076134474C155806632 @default.
• W2076134474 hasConceptScore W2076134474C2776694085 @default.
• W2076134474 hasConceptScore W2076134474C2776755627 @default.
• W2076134474 hasConceptScore W2076134474C2778227246 @default.
• W2076134474 hasConceptScore W2076134474C2778880634 @default.
• W2076134474 hasConceptScore W2076134474C2779083369 @default.
• W2076134474 hasConceptScore W2076134474C2780147359 @default.
• W2076134474 hasConceptScore W2076134474C2780387249 @default.
• W2076134474 hasConceptScore W2076134474C2780739268 @default.
• W2076134474 hasConceptScore W2076134474C2781413609 @default.
• W2076134474 hasConceptScore W2076134474C2908786992 @default.
• W2076134474 hasConceptScore W2076134474C502942594 @default.
• W2076134474 hasConceptScore W2076134474C509974204 @default.
• W2076134474 hasConceptScore W2076134474C71924100 @default.
• W2076134474 hasIssue "4" @default.
• W2076134474 hasLocation W20761344741 @default.
• W2076134474 hasLocation W20761344742 @default.
• W2076134474 hasOpenAccess W2076134474 @default.
• W2076134474 hasPrimaryLocation W20761344741 @default.
• W2076134474 hasRelatedWork W2013237588 @default.
• W2076134474 hasRelatedWork W2039368436 @default.
• W2076134474 hasRelatedWork W2076134474 @default.
• W2076134474 hasRelatedWork W2171206477 @default.
• W2076134474 hasRelatedWork W2171635737 @default.
• W2076134474 hasRelatedWork W2246100332 @default.

• next